表紙:非ステロイド性抗炎症薬の世界市場:2021年~2027年
市場調査レポート
商品コード
1064784

非ステロイド性抗炎症薬の世界市場:2021年~2027年

Global Non-steroidal anti-inflammatory drugs Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 123 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
非ステロイド性抗炎症薬の世界市場:2021年~2027年
出版日: 2022年02月01日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文 123 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の非ステロイド性抗炎症薬の市場規模は、予測期間中に大幅なCAGRで拡大すると予測されています。痛みと炎症を引き起こす疾患の有病率の上昇は、同市場の成長を促進する重要な要因です。また、オピオイドよりも非ステロイド性抗炎症薬を好む人が増えていることも、市場の成長を促す主な要因となっています。

当レポートでは、世界の非ステロイド性抗炎症薬市場について調査し、市場の概要とともに、投与経路別、用途別、流通チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場の機会

第4章 市場セグメンテーション

  • 世界の非ステロイド性抗炎症薬市場、投与経路別
    • 経口
    • 非経口
  • 世界の非ステロイド性抗炎症薬市場、用途別
    • 関節炎
    • 片頭痛
    • 眼科疾患
    • その他
  • 世界の非ステロイド性抗炎症薬市場、流通チャネル別
    • 院内薬局
    • 小売薬局
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第6章 企業プロファイル

  • Amgen Inc.
  • Astrazeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Horizon Therapeutics Plc
  • Johnson & Johnson.
  • Novartis AG.
  • Pfizer Inc.
  • Zyla Lifesciences
図表

LIST OF TABLES

  • 1. GLOBAL NSAIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027 ($ MILLION)
  • 2. GLOBAL ORAL NSAIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL PARENTERAL NSAIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL NSAIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 5. GLOBAL NSAIDS FOR ARTHRITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL NSAIDS FOR MIGRAINE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL NSAIDS FOR OPHTHALAMIC DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL NSAIDS FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL NSAIDS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 10. GLOBAL NSAIDS FOR HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL NSAIDS FOR RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL NSAIDS FOR OTHER DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL NSAIDS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICAN NSAIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN NSAIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN NSAIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN NSAIDS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 18. EUROPEAN NSAIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. EUROPEAN NSAIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027 ($ MILLION)
  • 20. EUROPEAN NSAIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 21. EUROPEAN NSAIDS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC NSAIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC NSAIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC NSAIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC NSAIDS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD NSAIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD NSAIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 28. REST OF THE WORLD NSAIDS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NSAIDS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2020 VS 2027 (%)
  • 2. GLOBAL NSAIDS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL NSAIDS MARKET SHARE BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
  • 4. GLOBAL NSAIDS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. US NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. CANADA NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. UK NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. FRANCE NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. GERMANY NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. ITALY NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. SPAIN NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. REST OF EUROPE NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. INDIA NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. CHINA NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. JAPAN NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF THE WORLD NSAIDS MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2024278

Global Non-steroidal anti-inflammatory drugs (NSAIDs) Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Parenteral) by Application (Arthritis, Migraine, Ophthalmic Diseases, Other) by Distribution channel (Hospital Pharmacies, Retail Pharmacies, Others Distribution Channels) and Forecast (2020-2026)

The global Non-steroidal anti-inflammatory drugs (NSAIDs) market is anticipated to grow at a considerable CAGR during the forecast period. The increasing prevalence of pain and inflammation causing disorders is a key factor driving the growth of the global NSAIDs market. The rising preference of NSAIDs over opioids is another major factor driving its market growth.

The global NSAIDs market is segmented based on route of administration, application, and distribution channel. Based on route of administration, the NSAIDs market is segmented into oral and parenteral. Based on application, the NSAIDs market is segmented into arthritis, migraine, ophthalmic diseases, and other. Based on distribution channel, the NSAIDs market is segmented into hospital pharmacies, retail pharmacies, and others distribution channels.

Geographically, the global NSAIDs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global NSAIDs market include Pfizer Inc., Amgen Inc., GlaxoSmithKline PLC., Johnson & Johnson., Novartis AG., and F. Hoffmann-La Roche AG., among others.

Market Segmentation

1. Global NSAIDs Market Research and Analysis by Route of Administration

2. Global NSAIDs Market Research and Analysis by Application

3. Global NSAIDs Market Research and Analysis by Distribution Channel

The Report Covers

  • Comprehensive research methodology of the global NSAIDs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global NSAIDs market.
  • Insights about market determinants that are stimulating the global NSAIDs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global NSAIDs Market by Route of Administration
    • 4.1.1. Orals
    • 4.1.2. Parenteral
  • 4.2. Global NSAIDs Market by Application
    • 4.2.1. Arthritis
    • 4.2.2. Migraine
    • 4.2.3. Ophthalmic Diseases
    • 4.2.4. Other
  • 4.3. Global NSAIDs Market by Distribution Channel
    • 4.3.1. Hospital Pharmacies
    • 4.3.2. Retail Pharmacies
    • 4.3.3. Other

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Amgen Inc.
  • 6.2. Astrazeneca Plc
  • 6.3. Bayer AG
  • 6.4. F. Hoffmann-La Roche AG
  • 6.5. GlaxoSmithKline PLC
  • 6.6. Horizon Therapeutics Plc
  • 6.7. Johnson & Johnson.
  • 6.8. Novartis AG.
  • 6.9. Pfizer Inc.
  • 6.10. Zyla Lifesciences